Overview
Location
United Kingdom
Total raised
$6.72M
Funding Rounds 1
| Date | Series | Amount | Investors |
| Sign up to see | Sign up to see | Sign up to see | Sign up to see |
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| May 27, 2026 | iFAST Diagnostics bags £5M to speed up infection testing and tackle antimicrobial resistance | UK biotech iFAST Diagnostics has closed a £5 million funding round. iFAST is addressing the $4 billion (and growing) Antimicrobial Susceptibility Testing (AST) market. It has developed a test delivering results in under three hours from a p... |
| Nov 5, 2024 | London-based iFAST Diagnostics secures over 5.9 million to combat antimicrobial resistance globally | iFAST Diagnostics, a UK-based diagnostics innovator, has announced the successful close of a €5.9 million seed funding round led by KHP Ventures, a medtech-focused investment fund backed by the NHS, and saw participation from new investors,... |
| iFast Diagnostics | “IFAST – Antimicrobial Susceptibility Testing” |
Reviews 0
FAQ about iFast Diagnostics
How much funding has iFast Diagnostics raised?
iFast Diagnostics has raised $6.72M in total across 1 funding round.
What has the press written about iFast Diagnostics?
Parsers VC has collected 4 articles mentioning iFast Diagnostics, among them “iFAST Diagnostics bags £5M to speed up infection testing and tackle antimicrobial resistance” (May 27, 2026) and “London-based iFAST Diagnostics secures over 5.9 million to combat antimicrobial resistance globally” (Nov 5, 2024).
Is iFast Diagnostics still active?
iFast Diagnostics is probably closed: its latest activity on Parsers VC dates from Jun 1, 2026.